Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -0.27EBITDA per Share
VS
Market
Sector
Industry
History
$ 1.21Close
$ 0.45 - $ 2.21 52-Week Range
Ticker Information
Ticker
KAPACompany Name
KAIROS PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTKAIROS PHARMA LTD - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KAPA - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -4.7M | $ -0.27 | 1 | 17.21M |
| 3/31/2025 | $ -3.56M | $ -0.22 | 1 | 15.88M |
| 12/31/2024 | $ -2.57M | $ -0.23 | 1 | 11.36M |
| 9/30/2024 | $ -2.54M | $ -0.23 | 1 | 10.91M |
| 6/30/2024 | $ 0 | $ 0 | 1 | 10.56M |
| 3/31/2024 | $ 0 | $ 0 | 1 | 10.56M |
| 12/31/2023 | $ -1.61M | $ -0.16 | 1 | 10.38M |
| 9/30/2023 | $ 0 | $ 0 | 1 | 10.33M |
| 12/31/2022 | $ -839K | $ -0.08 | 1 | 10.24M |
Key Performance Insights, Last 5 Years
- KAIROS PHARMA LTD's latest trailing twelve months (TTM) EBITDAPS stands at $ -0.08.
- Over the past 5 years, KAIROS PHARMA LTD's average EBITDAPS has been $ -0.2.
- The median EBITDAPS for KAIROS PHARMA LTD during this period was $ -0.23
- KAIROS PHARMA LTD reached its highest EBITDAPS over the past 5 years at $ -0.08.
- The lowest EBITDAPS recorded by KAIROS PHARMA LTD in the same timeframe $ -0.27
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for KAIROS PHARMA LTD is calculated as follows: EBITDA [ $ -839K ] / (Shares WA [ 10.24M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0.08 ] KAPA - EBITDA per Share, Last 5 years
$ -0.27
Minimum
Jun 30, 2025
$ -0.08
Maximum
Dec 31, 2022
$ -0.2
Average
$ -0.23
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |